Banta, D. and E. Jonsson. 2009. “History of HTA: Introduction.” International Journal of Technology Assessment in Health Care 25(S1), 1 – 6.10.1017/S0266462309090321
Bodenheimer, T. 2005. “High and Rising Health Care Costs. Part 2: Technologic Innovation.” Annals of Internal Medicine 142(11), 932 – 937.10.7326/0003-4819-142-11-200506070-00012
Ciani, O., P. Armeni, P. R. Boscolo, M. Cavazza, C. Jommi and R. Tarricone. 2016. “De Innovatione: The Concept of Innovation for Medical Technologies and its Implications for Healthcare Policy-Making.” Health Policy and Technology 5(1), 47 – 64.10.1016/j.hlpt.2015.10.005
Cookson, R. and J. Hutton. 2003. “Regulating the Economic Evaluation of Pharmaceuticals and Medical Devices: A European Perspective.” Health Policy 63(2), 167 – 178.10.1016/S0168-8510(02)00063-5
Drummond, M., A. Griffin and R. Tarricone. 2009. “Economic Evaluation for Devices and Drugs, Same or Different ?” Value in Health 12(4), 402 – 404.10.1111/j.1524-4733.2008.00476_1.x
EUnetHTA Joint Action 2: Work Package 8.2016. HTA Core Model ® version 3.0 (Pdf): EUnetHTA. Available at www.htacoremodel.info/BrowseModel.aspx (last accessed 20 September 2020).
Friedberg, M., B. Saffran, T. J. Stinson, W. Nelson and C. L. Bennett. 1999. “Evaluation of Conflict of Interest in Economic Analyses of New Drugs used in Oncology.” Jama 282(15), 1453 – 1457.10.1001/jama.282.15.1453
Gajdošová, E. 2018. “New Technologies as One of Key Drivers of Healthcare Spending Growth in the Czech Republic.” In Petra Dvořáková (ed.). Current Trends in Public Sector Research. Brno: Masarykova univerzita, 244 – 251.
Garrido, M. V., A. Gerhardus, J. A. Røttingen and R. Busse. 2010. “Developing Health Technology Assessment to Address Health Care System Needs.” Health Policy 94(3), 196 – 202.10.1016/j.healthpol.2009.10.002
Garrido, M. V., F. B. Kristensen, C. P. Nielsen and R. Busse. 2008. Health Technology Policy-Making in Europe: Current Status, Challenges and Potential. United KingdomPlace: World Health Organization.
Goodman, C. 2004. HTA 101: Introduction to Health Technology Assessment. USA: US National Library of Medicine, National Institutes of Health, National Information Center on Health Services Research and Health Care Technology (NICHSR).
Gulácsi, L., A. M. Rotar, M. Niewada, O. Löblová, F. Rencz, G. Petrova and N. S. Klazinga. 2014. “Health Technology Assessment in Poland, the Czech Republic, Hungary, Romania and Bulgaria.” European Journal of Health Economics 15(1), 13 – 25.10.1007/s10198-014-0590-8
Hartz, S. and J. John. 2009. “Public Health Policy Decisions on Medical Innovations: What Role can Early Economic Evaluation Play ?” Health Policy 89(2), 184 – 192.10.1016/j.healthpol.2008.05.011
Hjelmgren, J., F. Berggren and F. Andersson. 2001. “Health Economic Guidelines: Similarities, Differences and Some Implications.” Value in Health 4(3), 225 – 250.10.1046/j.1524-4733.2001.43040.x
Kaló, Z., A. Gheorghe, M. Huic, M. Csanádi and F. B. Kristensen. 2016. “HTA Implementation Roadmap in Central and Eastern European Countries.” Health Economics 25, 179 – 192.10.1002/hec.3298
Kirisits, A. and W. K. Redekop. 2013. “The Economic Evaluation of Medical Devices.” Applied Health Economics and Health Policy 11(1), 15 – 26.10.1007/s40258-012-0006-9
Lamovsek, N. and M. Klun. 2020. “Efficiency of Medical Laboratories after Quality Standard Introduction: Trend Analysis of Selected EU Countries and Case Study from Slovenia.” Cent. Eur. Pub. Admin. Rev. 18, 143.10.17573/cepar.2020.1.07
Lampe, K., M. Mäkelä, M. V. Garrido, H. Anttila, I. Autti-Rämö, N. J. Hicks and A. Malmivaara. 2009. “The HTA Core Model: A Novel Method for Producing and Reporting Health Technology Assessments.” International Journal of Technology Assessment in Health Care 25(S2), 9 – 20.10.1017/S0266462309990638
Lawson, C. and J. Nemec. 1998. “Central European Health Reform: The Case of Slovakia, 1990 – 97.” Journal of European Social Policy 8(3), 237 – 252.10.1177/095892879800800303
Medveď, J., J. Nemec and L. Vítek. 2005. “Social Health Insurance and its Failures in the Czech Republic and Slovakia: The Role of the State.” Prague Economic Papers 14(1).10.18267/j.pep.253
Ministry of Health (MoH). 2013. Hodnocení zdravotnických technologií: Tvorba metodických postupů a realizace zkušebního hodnocení (seminář 21. 6. 2013). Available at https://www.mzcr.cz/obsah/novinky_114_129_1.html (last accessed 6 July 2020).
Ministry of Health (MoH). 2018. O přístrojové komisi. Praha: Ministerstvo zdravotnictví ČR. Available at https://www.mzcr.cz/o-pristrojove-komisi/ (last accessed 19 September 2020).
Ministry of Health (MoH). 2019. Hodnocení vývoje systému veřejného zdravotního pojištění v roce 2019. Praha: Ministerstvo zdravotnictví ČR. Available at https://www.psp.cz/sqw/text/tiskt.sqw?O=8&CT=1050&CT1=0 (last accessed 19 January 2021).
Mueller, D., D. Tivey and D. Croce. 2017. “Health-Technology Assessment: Its Role in Strengthening Health Systems in Developing Countries.” Strengthening Health Systems 2(1), 6 – 11.
Nemec, J., M. Kubák, G. Donin and Z. Kotherová. 2021. “Efficiency of Public Procurement in the Czech and Slovak Health Care Sectors.” Transylvanian Review of Administrative Sciences 17(62), 115 – 133.10.24193/tras.62E.7
Nemec, J., D. Spacek and M. de Vries. 2015. “Coordinating Healthcare under a Pluralistic Health Insurance System: The Case of Slovakia.” Transylvanian Review of Administrative Sciences 11(45), 168 – 184.
Peter, L., L. Hajek, P. Maresova, M. Augustynek and M. Penhaker. 2020. “Medical Devices: Regulation, Risk Classification, and Open Innovation.” Journal of Open Innovation: Technology, Market, and Complexity 6(2), 42.10.3390/joitmc6020042
Ramsay C. R., A. M. Grant, S. A. Wallace et al. 2001. “Statistical Assessment of the Learning Curves of Health Technologies.” Health Technol Assess 5(12), 1 – 79.10.3310/hta5120
Siebert, M., L. C. Clauss, M. Carlisle, B. Casteels, P. De Jong, M. Kreuzer and A. W. Lang. 2002. “Health Technology Assessment for Medical Devices in Europe.” International Journal of Technology Assessment in Health Care 18(3), 733 – 740.
Sorenson, C., M. Drummond and B. B. Khan. 2013. “Medical Technology as a Key Driver of Rising Health Expenditure: Disentangling the Relationship.” ClinicoEconomics and Outcomes Research: CEOR 5, 223.10.2147/CEOR.S39634
Tarricone, R., G. Callea, M. Ogorevc and V. Prevolnik Rupel. 2017. “Improving the Methods for the Economic Evaluation of Medical Devices.” Health Economics 26(S1), 70 – 92.10.1002/hec.3471
Tarricone, R., A. Torbica, F. Ferre and M. Drummond. 2014. “Generating Appropriate Clinical Data for Value Assessment of Medical Devices: What Role does Regulation Play ?” Expert Review of Pharmacoeconomics & Outcomes Research 14(5), 707 – 718.10.1586/14737167.2014.950233
Taylor, R. S. and C. P. Iglesias. 2009. “Assessing the Clinical and Cost-Effectiveness of Medical Devices and Drugs: Are they that Different ?” Value in Health 12(4), 404 – 406.10.1111/j.1524-4733.2008.00476_2.x
Vitezić, N., S. S. Cankar and Ž. Linšak. 2019. “Effectiveness Measurement Using DEA & BSC Methods in Public Health Services.” NISPAcee Journal of Public Administration and Policy 12(1), 199 – 216.10.2478/nispa-2019-0009